Health Minister Hala Zayed has agreed to look into repricing 330 meds manufactured by state-owned companies, Public Enterprises Minister Hisham Tawfik tells Al Mal. According to Tawfik, the repricing will not necessarily entail an increase in the retail price, and will assess possible scenarios to reduce manufacturing costs. He did note that some of these meds are currently being sold at less than their cost of production. This comes as private pharma companies are also pushing to raise med prices, saying the most recent increases in fuel prices and electricity tariffs, along with a global rise in the cost of raw materials made raising med prices a necessity.
More from Enterprise
Banque du Caire opens its IPO books at EGP 4.82-5.30 a share, with room to grow to 45%
The state-owned lender could raise up to EGP 36.4 bn,…
Inside the financing of Egypt’s IPP boom
The contracts and the resources are proven, so the open…
FRA and EGX eye law change to let LLCs and partnerships set up investment funds
Regulators want to keep Egyptian money from setting up funds…
Egyptian-UK fintech Zeal raises USD 10 mn to back expansion plans
The London-based, Egyptian-founded fintech is preparing to activate its loyalty…